Oxford-Astrazeneca

Eight European Union (EU) countries, including Italy, Denmark and Norway, have halted use of the Oxford-AstraZeneca coronavirus vaccine. The reason: Fear of blood clot formation. The…

The process of vaccination against COVID-19 is on in full swing in several countries. But the debate continues on what is the ideal interval between jabs in case of those vaccines which…

Bhubaneswar: Indigenously developed Covaxin COVID-19 vaccine by Bharat Biotech is likely to be priced lower than Serum Institute's Covishield. Covishield will be sold at Rs 200 per vial…

New Delhi: Serum Institute of India (SII) and Bharat Biotech have not been granted emergency use authorisation of their coronavirus vaccine because of inadequate safety and efficacy data.…

London: The frontrunners in the race to develop a coronavirus vaccine continue to show positive results. After Pfizer and Moderna reported extremely encouraging data from final-stage…

Pune: The Serum Institute of India (SII) will start the third and final phase of human trial of Oxford-Astrazeneca’s coronavirus vaccine at Pune’s Sasson General Hospital early next week.…